Immune profiling leads to implications for immunotherapy for NF1-associated tumors
Neurofibromatosis type 1 (NF1) -- an autosomal dominant disorder affecting approximately one in every 3,500 people -- results in dysfunctional neurofibromin, a protein expressed throughout...




